BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26494234)

  • 1. Prostate cancer patients' report on communication about endocrine therapy and its association with adherence.
    Jung B; Stoll C; Feick G; Prott FJ; Zell J; Rudolph I; Huebner J
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):465-70. PubMed ID: 26494234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?
    Wuensch P; Hahne A; Haidinger R; Meißler K; Tenter B; Stoll C; Senf B; Huebner J
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):55-60. PubMed ID: 25085010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of patient education materials for the "German Prostate Cancer Trial PREFERE"].
    Sänger S; Wiegel T; Stöckle M; Härter M; Bergelt C
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(1):28-39. PubMed ID: 25839363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of perspectives on prostate cancer: analyses of survey data.
    Crawford ED; Bennett CL; Stone NN; Knight SJ; DeAntoni E; Sharp L; Garnick MB; Porterfield HA
    Urology; 1997 Sep; 50(3):366-72. PubMed ID: 9301699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The language of prostate cancer treatments and implications for informed decision making by patients.
    Rot I; Ogah I; Wassersug RJ
    Eur J Cancer Care (Engl); 2012 Nov; 21(6):766-75. PubMed ID: 22574619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCA: prostate cancer, patient-centred approach or both?
    Denis L; Joniau S; Bossi A; Baskin-Bey E; Fitzpatrick JM
    BJU Int; 2012 Jul; 110(1):16-22. PubMed ID: 22233268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Information seeking and satisfaction with physician-patient communication among prostate cancer survivors.
    Cegala DJ; Bahnson RR; Clinton SK; David P; Gong MC; Monk JP; Nag S; Pohar KS
    Health Commun; 2008; 23(1):62-9. PubMed ID: 18443993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Communication preferences of patients with prostate cancer : Preferences regarding the communication of bad news of patients with prostate cancer in Germany-results of an anonymous patient survey].
    Merseburger AS; Kramer MW; Scheithe K; Colling C
    Urologe A; 2016 Oct; 55(10):1339-1346. PubMed ID: 27306355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician beliefs about antiretroviral adherence communication.
    Roberts KJ
    AIDS Patient Care STDS; 2000 Sep; 14(9):477-84. PubMed ID: 11051630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related Internet use among patients of osteopathic physicians.
    Cooley DL; Mancuso AM; Weiss LB; Coren JS
    J Am Osteopath Assoc; 2011 Aug; 111(8):473-82. PubMed ID: 21862755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communicating effectively with the patient and family about treatment options for prostate cancer.
    Kunkel EJ; Myers RE; Lartey PL; Oyesanmi O
    Semin Urol Oncol; 2000 Aug; 18(3):233-40. PubMed ID: 10975496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial.
    Hack TF; Pickles T; Bultz BD; Ruether JD; Degner LF
    Psychooncology; 2007 Jun; 16(6):543-52. PubMed ID: 16991107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
    Davison BJ; Goldenberg SL
    BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Patients and the Internet: a Survey Among German Cancer Patients.
    Ebel MD; Stellamanns J; Keinki C; Rudolph I; Huebner J
    J Cancer Educ; 2017 Sep; 32(3):503-508. PubMed ID: 26553327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interest in services among prostate cancer patients receiving androgen deprivation therapy.
    Shapiro PJ; Coyne JC; Kruus LK; Palmer SC; Vaughn DJ; Malkowicz SB
    Psychooncology; 2004 Aug; 13(8):512-25. PubMed ID: 15295773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.
    Lorimer S; Cox A; Langford NJ
    J Clin Pharm Ther; 2012 Apr; 37(2):148-52. PubMed ID: 21592157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Navigating healthcare: a qualitative study exploring prostate cancer patients' and doctors' experience of consultations using a decision-support intervention.
    Hacking B; Scott SE; Wallace LM; Shepherd SC; Belkora J
    Psychooncology; 2014 Jun; 23(6):665-71. PubMed ID: 24677394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance.
    Davison BJ; Breckon E
    Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.